Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
Namit Chaudhary(Scripps Research Institute), Kathryn A. Whitehead(Carnegie Mellon University), Julie S. Kim(Carnegie Mellon University), Mariah L. Arral(Carnegie Mellon University), Rose Doerfler(Carnegie Mellon University), Samuel T. LoPresti(Carnegie Mellon University), Tiffany A. Coon(University of Pittsburgh), Yoel Sadovsky(Stanford Medicine), Catalina Montoya(Carnegie Mellon University), Saigopalakrishna S. Yerneni(Carnegie Mellon University), Alexandra N. Newby(Carnegie Mellon University), Daria M. Strelkova Petersen(Carnegie Mellon University), Bethany Fox(Carnegie Mellon University), Angela Malaney(Carnegie Mellon University)
Cited by 40
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628
Managing diabetes with nanomedicine: challenges and opportunities
|Nature Reviews Drug Discovery|2014|608
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
|Journal of Controlled Release|2022|270